Acolbifene

Source: Wikipedia, the free encyclopedia.
Acolbifene
Clinical data
Other namesEM-652; SCH-57068
Drug classSelective estrogen receptor modulator
Identifiers
  • (2S)-3-(4-hydroxyphenyl)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2H-chromen-7-ol
JSmol)
  • CC1=C([C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O
  • InChI=1S/C29H31NO4/c1-20-26-14-11-24(32)19-27(26)34-29(28(20)21-5-9-23(31)10-6-21)22-7-12-25(13-8-22)33-18-17-30-15-3-2-4-16-30/h5-14,19,29,31-32H,2-4,15-18H2,1H3/t29-/m0/s1
  • Key:DUYNJNWVGIWJRI-LJAQVGFWSA-N

Acolbifene (

INNTooltip International Nonproprietary Name) (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator (SERM) which, as of 2015, is in phase III clinical trials for the treatment of breast cancer.[1][2]

See also

References

  1. S2CID 45909360
    .
  2. ^ "Acolbifene - Endoceutics". Adis Insight. Springer Nature Switzerland AG.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Acolbifene&oldid=1196780110"